MacroGenics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -12.2% | -16.8% | -19.0% | +31.5% | -1.1% | -14.2% | +9.3% | +10.3% | -5.1% | -15.2% | +58.5% | |
| – | -13.7% | -19.4% | -22.5% | +41.6% | -2.1% | -16.3% | +12.6% | +13.2% | -5.2% | -17.0% | +76.2% | |
| – | +12.3% | -20.4% | +4.5% | +114.0% | +1.8% | -20.4% | -10.2% | -38.7% | -28.6% | +16.3% | +71.2% | |
| – | -10.4% | -19.8% | -23.8% | +42.7% | +0.7% | -23.6% | +14.5% | -17.0% | +29.7% | -18.8% | +12.4% | |
| – | -59.0% | -30.4% | -14.2% | +41.3% | -50.8% | +144.7% | +18.9% | +452.4% | -80.7% | -22.0% | +1,283.0% | |
| – | +14.5% | +2.2% | -10.7% | +190.9% | -100.0% | – | -1.6% | -5.7% | -9.6% | +20.1% | – | |
| – | -0.1% | -2.5% | +0.8% | +0.8% | +0.8% | -0.1% | +36.7% | +2.5% | -1.2% | -2.3% | +53.8% | |
| – | +9.4% | -0.6% | +3.8% | +2.4% | -6.4% | -0.2% | -29.7% | +14.0% | -3.0% | +122.5% | +13.4% | |
| – | -3.8% | +8.2% | +7.9% | +7.7% | +2.5% | +10.3% | -4.6% | +0.4% | +0.7% | +0.7% | -4.6% | |
| – | +95.1% | +66.0% | -51.0% | +26.3% | -24.2% | +32.0% | -29.6% | +27.5% | -19.4% | -10.4% | -19.7% | |
| – | -21.3% | -30.4% | -45.5% | +107.7% | -3.3% | -31.8% | -41.1% | +43.7% | -17.0% | -61.9% | +102.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.5% | +0.6% | +0.6% | +0.3% | -0.4% | +0.5% | +0.3% | +0.2% | -0.2% | +0.5% | +0.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.